BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
![](https://www.pinterest.com/pin/create/button/?url=https://econotimes.com/Sanofi-Filing-of-the-2016-US-Form-20-F-and-French-Document-de-Rfrence-containing-the-Annual-Financial-Report-572603/&media=https://www.econotimes.com/assets/images/econotimes/metaDefault.png&description=Sanofi: Filing of the 2016 U.S. Form 20-F and French "Document de Référence" containing the Annual Financial Report - EconoTimes)
Filing of the 2016 U.S. Form 20-F and French "Document de Référence" containing the Annual Financial Report
Paris, France - March 3, 2017 - Sanofi announces today the filing of its Form 20-F with the U.S. Securities and Exchange Commission (SEC) and its "Document de Référence" containing its Annual Financial Report with the French market regulator Autorité des marchés financiers (AMF).
These documents are available on the "Investors" page of the company's corporate website (www.sanofi.com), under the heading "Regulated Information in France". In addition, the Form 20-F is available on the website of the SEC (www.sec.gov) and the "Document de Référence" is available on the website of the AMF (www.amf-france.org). A hard copy of these documents, each of which contains our complete audited financial statements, may be received free of charge, upon request.
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Consumer Healthcare. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Contacts:
| Media Relations Laurence Bollack Tel: + (33) 1 53 77 46 46 [email protected] | Investor Relations George Grofik Tel.: + (33) 1 53 77 45 45 [email protected] |
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/7e5eba72-9d79-4a4c-81e7-6ead57645fd3
